The mission of the Behavioral and Social Sciences Core (Core F) is to identify, foster and support new opportunities for social and behavioral research in HIV/AIDS that both serve the needs of CFAR investigators and enable research in emerging CFAR and national scientific priorities. Core F strives to facilitate scientific and operational linkages between CFAR behavioral and social scientists and clinical and basic science investigators;lead the Penn CFAR in developing meaningful community partnerships, and enable the HIV/AIDS research agenda in areas of high opportunity and synergy including the new Scientific Working Group in HIV and Substance Use research and through collaborations with the new Philadelphia Mental Health AIDS Research Center. The Core is led by Drs. David Metzger (Core Director), Michael Blank (Co-Director) and Tiffany Dominique (Core Coordinator). To accomplish its mission, Core F has the following aims: (1) To provide research application and implementation support services. This service is devoted to the identification and communication of funding opportunities, the identification of new and transitioning investigators and providing support to them in developmental and NIH applications, and the provision of support for funded NIH investigators;(2) To provide target populations service. This service is designed to support innovative approaches to the recruitment, assessment, and specimen collection from populations of interest to prevention, therapeutic and basic science investigators;(3)

Mentoring

education, training, and support for research tools library. Core F places a high priority on the development of early career and transitioning investigators through intra and cross-CFAR mentoring, the hosting of AIDS research fellowships, sponsoring and delivery of invited speakers and training events, and the maintenance of a library of software and other research tools useful in the conduct of AIDS related research;(4) Community integration services. The Core provides programmatic and budgetary support for the Penn CFAR Community Advisory Board in its vibrant agenda and national leadership promoting bi-directional linkages between AIDS researchers and the community, as well as growing linkages with the Philadelphia Health Department to support the emerging research agenda focused on engagement in care.

Public Health Relevance

To support innovative, forward-looking research on HIV/AIDS and social and behavioral issues. Core F is focused on: (a) identifying and supporting early career and transitioning investigators;(b) cross core collaborations;(c) inter-CFAR collaborations;and (d) spearheading the community integration efforts of the Penn CFAR. Core F evaluates its services to ensure they are useful to funded investigators, scientifically meaningful, and sustainable.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI045008-16
Application #
8697326
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
16
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Venuto, Charles S; Lim, Jihoon; Messing, Susan et al. (2018) Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s. Antivir Ther 23:345-351
Clarke, Erik L; Lauder, Abigail P; Hofstaedter, Casey E et al. (2018) Microbial Lineages in Sarcoidosis. A Metagenomic Analysis Tailored for Low-Microbial Content Samples. Am J Respir Crit Care Med 197:225-234
Barbian, Hannah J; Connell, Andrew Jesse; Avitto, Alexa N et al. (2018) CHIIMP: An automated high-throughput microsatellite genotyping platform reveals greater allelic diversity in wild chimpanzees. Ecol Evol 8:7946-7963
Meyers, Kathrine; Rodriguez, Kristina; Brill, Atrina L et al. (2018) Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants. AIDS Behav 22:1209-1216
Abdel-Mohsen, Mohamed; Kuri-Cervantes, Leticia; Grau-Exposito, Judith et al. (2018) CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. Sci Transl Med 10:
Barbian, Hannah J; Li, Yingying; Ramirez, Miguel et al. (2018) Destabilization of the gut microbiome marks the end-stage of simian immunodeficiency virus infection in wild chimpanzees. Am J Primatol 80:
Ke, Ruian; Li, Hui; Wang, Shuyi et al. (2018) Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence. Proc Natl Acad Sci U S A 115:E7139-E7148
Park, Yoon-Dong; Jarvis, Joseph N; Hu, Guowu et al. (2018) Transcriptional Profiling of Patient Isolates Identifies a Novel TOR/Starvation Regulatory Pathway in Cryptococcal Virulence. MBio 9:
MacBrayne, Christine E; Marks, Kristen M; Fierer, Daniel S et al. (2018) Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate. J Antimicrob Chemother 73:2112-2119
Veenhuis, Rebecca T; Kwaa, Abena K; Garliss, Caroline C et al. (2018) Long-term remission despite clonal expansion of replication-competent HIV-1 isolates. JCI Insight 3:

Showing the most recent 10 out of 775 publications